Skip to main content
Clinical Trials/TCTR20210924008
TCTR20210924008
Not yet recruiting
Phase 3

Comparison of a 1.25 mg/ml intralesional triamcinolone acetonide with combination of a 1.25 mg/ml intralesional triamcinolone acetonide and comedone extraction in healing of inflammatory acnes in moderate-to-severe adult acne: a randomized, split-face controlled trial

Dermatology unit, department of internal medicine, Chulalongkorn university0 sites40 target enrollmentSeptember 24, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
moderate to severe acne
Sponsor
Dermatology unit, department of internal medicine, Chulalongkorn university
Enrollment
40
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 24, 2021
End Date
February 1, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dermatology unit, department of internal medicine, Chulalongkorn university

Eligibility Criteria

Inclusion Criteria

  • 1\. moderate\-to\-severe acne patients with equally distributed acne papules on both sides of one's face (different papules no more than 5 papules)
  • 2\. no prior history of procedure on the papules such as chemical peeling, laser
  • 3\. The volunteers have their own cell phones in which the camera's pixel is more than 7 million pixel

Exclusion Criteria

  • 1\. allergic to triamcinolone acetonide
  • 2\. can't tolerate intralesional procedure and comedone extraction
  • 3\. psychiatric problem
  • 4\. willing to do other procedures (such as chemical peeling, laser) during the research period (6 month)
  • 5\. history of prior keloid and hypertrophic scar

Outcomes

Primary Outcomes

Not specified

Similar Trials